ISRCTN17977921已完成未知
A randomized controlled study of tacrolimus for the treatment of idiopathic membranous nephropathy
The First Affiliated Hospital of Zhengzhou University (China)0 个研究点目标入组 120 人开始时间: 2016年5月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients with idiopathic membranous nephropathy confirmed by renal biopsy (light microscopy + SEM)
- •2. Clinical manifestations of nephrotic syndrome
- •3. Persistent serum creatinine < 115 mmol/L or the reference value of creatinine
- •4. Any age group, male or female
排除标准
- •1. Secondary MN with hepatitis or malignant tumor
- •2. Use of steroids, cytotoxic drugs, or immunosuppressants within 3 months of this study
- •3. Other severe organ diseases
- •4. Fasting blood glucose > 6.2 mmol/L or confirmed diabetes
- •5. Pregnant or nursing women
研究者
相似试验
进行中（未招募）
1 期
A randomised prospective trial of tacrolimus-based steroid avoidance in renal transplantation with either alemtuzumab induction or, basiliximab induction and mycophenolate mofetil maintenance therapy - SALAMIMabCampath / Alemtuzumab will be used as part of the immunosuppression regime following renal transplant.EUCTR2006-000830-11-GBeeds Teaching Hospitals NHS Trust120
已完成
不适用
Randomised study for immunosuppression regimen in liver transplantatioHepatitis C virus (HCV)-induced cirrhosisDigestive SystemFibrosis and cirrhosis of liverISRCTN94834276Royal Free Hampstead NHS Trust (UK)110
招募中
不适用
Examination of efficacy and safety of tacrolimus, immunomodulator for an outpatient with moderate to severe ulcerative colitisulcerative colitisJPRN-UMIN000005824Juntendo University20
尚未招募
2 期
Double blind, placebo controlled study Tacrolimus versus Emmolient in localized sclerodermamorphoea10010761localized sclerodermaNL-OMON31329niversitair Medisch Centrum Sint Radboud20
已完成
4 期
A comparative study of the efficacy of tacrolimus with infliximab in intractable ulcerative colitislcerative colitisJPRN-UMIN000010612Department of Internal Medicine, Division of Gastroenterology and Hepatology, Keio University School of Medicine130